Iminosugars and methods of treating Filoviral diseases

Iminosugars and methods of treating Filoviral diseases

The present application relates to iminosugars and methods of treating viral infections with iminosugars and, in particular, to the use of iminosugars for treatment and/or prevention of viral infections caused by or associated with a virus belonging to the Filoviridae family.

Bibliographic Details
Main Authors:	Ramstedt, U, Klose, B, Zitzmann, N, Dwek, R, Butters, T
Format:	Patent
Published:	World Intellectual Property Ogranization 2011

Similar Items

Iminosugars and methods of treating viral diseases
by: Ramstedt, U, et al.
Published: (2011)

Iminosugars and methods of treating Bunyaviral and Togaviral diseases
by: Ramstedt, U, et al.
Published: (2010)

Iminosugars and methods of treating Arenaviral infections
by: Ramstedt, U, et al.
Published: (2010)

Methods of treating Poxviral Infections
by: Ramstedt, U, et al.
Published: (2011)

Methods of treating orthomyxoviral infections
by: Ramstedt, U, et al.
Published: (2012)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
by: Butters, T, et al.
Published: (2005)

Use of iminosugar derivatives to inhibit ion channel activity
by: Zitzmann, N, et al.
Published: (2004)

Iminosugar antivirals: the therapeutic sweet spot
by: Alonzi, D, et al.
Published: (2017)

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
by: Durantel, D, et al.
Published: (2001)

Iminosugar for treatment of tumors
by: Dwek, R, et al.
Published: (2008)

Antiviral effects of an iminosugar derivative on flavivirus infections.
by: Wu, S, et al.
Published: (2002)

Filoviral Immune Evasion Mechanisms
by: Christopher F. Basler, et al.
Published: (2011-09-01)

Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
by: Steinmann, E, et al.
Published: (2007)

Filoviral haemorrhagic fevers: A threat to Zambia?
by: Katendi Changula, et al.
Published: (2012-06-01)

Infection control during filoviral hemorrhagic fever outbreaks
by: N Raabe Vanessa, et al.
Published: (2012-01-01)

Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
by: Norris-Cervetto, E, et al.
Published: (2006)

Iminosugars: promising therapeutics for influenza infection
by: Tyrrell, B, et al.
Published: (2016)

A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
by: Kelly L. Warfield, et al.
Published: (2015-05-01)

Long alkylchain iminosugars block the HCV p7 ion channel
by: Pavlovic, D, et al.
Published: (2005)

Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.
by: Durantel, D, et al.
Published: (2004)

Mechanisms of antiviral activity of iminosugars against dengue virus
by: Miller, JL, et al.
Published: (2018)

Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo.
by: Miller, J, et al.
Published: (2012)

Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response
by: Sayce, AC, et al.
Published: (2021)

The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives.
by: Pavlović, D, et al.
Published: (2003)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease
by: Boucheron, C, et al.
Published: (2005)

Iminosugars in combination with interferon and ribavirin permanently eradicate noncytopathic bovine viral diarrhea virus from persistently infected cells.
by: Woodhouse, S, et al.
Published: (2008)

Detection of biomarkers for filoviral infection with a silicon photonic resonator platform
by: Krista Meserve, et al.
Published: (2022-12-01)

Minimal in vivo efficacy of iminosugars in a lethal ebola virus guinea pig model
by: Miller, J, et al.
Published: (2016)

Bypass of quality control in protein folding pathways induces specific misfolding of HIV envelope V2 loop: implications for iminosugars as antivirals
by: Spiro, S, et al.
Published: (2014)

Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage.
by: Paul W Fenimore, et al.
Published: (2012-01-01)

Iminosugars counteract the downregulation of the interferon gamma receptor by dengue virus
by: Miller, J, et al.
Published: (2019)

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
by: Elizabeth A Nelson, et al.
Published: (2017-04-01)

No evidence for drug resistance by iminosugar-based HCV assembly inhibitors in tissue culture
by: Steinmann, E, et al.
Published: (2010)

Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
by: Warfield, KL, et al.
Published: (2016)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease (vol 16, pg 1747, 2005)
by: Boucheron, C, et al.
Published: (2005)

α-Glucosidase inhibition of lactone intermediates of the iminosugar deoxynojirimycin
by: Wai Haan, Y, et al.
Published: (2019)

Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection.
by: Verena Krähling, et al.
Published: (2010-01-01)

Iminosugar NB-DNJ delays mortality in lethal model of dengue virus infection in mice
by: Beatty, P, et al.
Published: (2009)

Strain-specific antiviral activity of iminosugars against human influenza A viruses.
by: Hussain, S, et al.
Published: (2015)

New developments in treating glycosphingolipid storage diseases.
by: Platt, F, et al.
Published: (2005)